Guideline adherence of antidepressant treatment in outpatients with major depressive disorder: a naturalistic study
- 18 April 2017
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Archiv Fur Psychiatrie Und Nervenkrankheiten
- Vol. 267 (8), 711-721
- https://doi.org/10.1007/s00406-017-0798-6
Abstract
Little is known about guideline adherence of naturalistic antidepressant drug therapy in outpatients with major depressive disorder (MDD). The aim of the study was to analyze guideline adherence, especially regarding treatment length, treatment evaluation and medication change strategies. We investigated 889 patients with MDD who had been admitted for inpatient treatment and were enrolled in the early medication change trial (ClinicalTrials.gov NCT00974155). We investigated all patients at screening visit regarding previous outpatient drug treatment in the index episode, which was assessed by structured interviews. Demographic variables were obtained from patients and patients’ records. 51.0% of the patients had received previous drug treatment in the index episode, 56.6% were females, and their mean age was 40.0 years. In the 153 patients who were pharmacologically treated at least 8 weeks, medication was not changed in 129 (84.3%) patients. Patients who had a medication change in their index episode (n = 24, 15.7%) waited 71.1 weeks (±110.4) for their treatment optimization. Only 5 of those 153 patients (3.3%) had a dose increase, whereas 132 patients (86.3%) had no dose adaption at all. Antidepressant blood levels were measured in 46 patients (30.1%). We conclude that a large proportion of patients with MDD is not treated in adherence to treatment guidelines recommending treatment evaluation (e.g. therapeutic drug monitoring) and treatment change after 4 to 8 weeks in non-responders. Earlier treatment optimization may prevent long-term suffering of patients and may avoid inpatient treatment.Funding Information
- Bundesministerium für Bildung und Forschung (01KG0906)
This publication has 25 references indexed in Scilit:
- Major depression treatment in Germany–descriptive analysis of health insurance fund routine data and assessment of guideline-adherenceJournal of Affective Disorders, 2016
- Adherence to Medications: Insights Arising from Studies on the Unreliable Link Between Prescribed and Actual Drug Dosing HistoriesAnnual Review of Pharmacology and Toxicology, 2012
- Antidepressant monotherapy: A claims database analysis of treatment changes and treatment durationClinical Therapeutics, 2010
- Rationale and design of the randomised clinical trial comparing early medication change (EMC) strategy with treatment as usual (TAU) in patients with Major Depressive Disorder - the EMC trialTrials, 2010
- No evidence for switching the antidepressant: systematic review and meta‐analysis of RCTs of a common therapeutic strategyActa Psychiatrica Scandinavica, 2010
- Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysisThe Lancet, 2009
- Adherence to Antidepressant Treatment Among Privately Insured Patients Diagnosed With DepressionMedical Care, 2007
- Why can't GPs follow guidelines on depression?BMJ, 2000
- The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.1998
- The inventory for depressive symptomatology (IDS): Preliminary findingsPsychiatry Research, 1986